Mironov Vladimir, Kasyanov Vladimir, Markwald Roger R
Bioprinting Research Center, Department of Cell Biology and Anatomy, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
Trends Biotechnol. 2008 Jun;26(6):338-44. doi: 10.1016/j.tibtech.2008.03.001. Epub 2008 Apr 20.
The existing methods of biofabrication for vascular tissue engineering are still bioreactor-based, extremely expensive, laborious and time consuming and, furthermore, not automated, which would be essential for an economically successful large-scale commercialization. The advances in nanotechnology can bring additional functionality to vascular scaffolds, optimize internal vascular graft surface and even help to direct the differentiation of stem cells into the vascular cell phenotype. The development of rapid nanotechnology-based methods of vascular tissue biofabrication represents one of most important recent technological breakthroughs in vascular tissue engineering because it dramatically accelerates vascular tissue assembly and, importantly, also eliminates the need for a bioreactor-based scaffold cellularization process.
现有的用于血管组织工程的生物制造方法仍然基于生物反应器,极其昂贵、费力且耗时,而且没有自动化,而自动化对于经济上成功的大规模商业化至关重要。纳米技术的进步可以为血管支架带来额外的功能,优化血管移植物内部表面,甚至有助于引导干细胞分化为血管细胞表型。基于纳米技术的快速血管组织生物制造方法的发展是血管组织工程领域近年来最重要的技术突破之一,因为它极大地加速了血管组织的组装,而且重要的是,还消除了基于生物反应器的支架细胞化过程的需求。